Norges Bank Regenxbio Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

37 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$11.51 - $21.53 $1.7 Million - $3.18 Million	147,546 New	147,546 $1.73 Million
Q4 2023 Feb 09, 2024	BUY	$12.89 - $20.82 $2.84 Million - $4.59 Million	220,524 New	220,524 $3.96 Million
Q3 2023 Nov 13, 2024	BUY	$16.46 - $19.99 $4.46 Million - $5.42 Million	270,942 New	270,942 $4.46 Million
Q3 2023 Nov 13, 2023	SELL	$16.46 - $19.99 $5.38 Million - $6.53 Million	-326,618 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$17.23 - $21.71 $2.13 Million - $2.68 Million	123,396 Added 83.63%	270,942 $5.42 Million
Q2 2023 Aug 14, 2023	SELL	$17.23 - $21.71 $5.63 Million - $7.09 Million	-326,618 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$18.08 - $24.55 $4.9 Million - $6.65 Million	270,942 New	270,942 $5.12 Million
Q4 2022 Feb 14, 2023	BUY	$20.4 - $24.73 $6.66 Million - $8.08 Million	326,618 New	326,618 $7.41 Million
Q3 2022 Nov 13, 2023	BUY	$22.29 - $35.04 $7.28 Million - $11.4 Million	326,618 New	326,618 $8.63 Million
Q2 2022 Aug 14, 2023	BUY	$19.35 - $35.04 $6.32 Million - $11.4 Million	326,618 New	326,618 $8.07 Million
Q1 2022 May 12, 2023	BUY	$24.62 - $34.31 $535,755 - $746,619	21,761 Added 6.66%	348,379 $11.6 Million
Q1 2022 May 09, 2022	SELL	$24.62 - $34.31 $8.58 Million - $12 Million	-348,379 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$30.19 - $40.28 $10.5 Million - $14 Million	348,379 New	348,379 $11.4 Million
Q3 2021 Nov 14, 2022	BUY	$29.09 - $45.68 $9.32 Million - $14.6 Million	320,530 New	320,530 $13.4 Million
Q3 2021 Nov 05, 2021	SELL	$29.09 - $45.68 $9.12 Million - $14.3 Million	-313,563 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$32.46 - $40.48 $10.2 Million - $12.7 Million	313,563 New	313,563 $12.2 Million
Q2 2021 Aug 10, 2021	SELL	$32.46 - $40.48 $11 Million - $13.7 Million	-339,135 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$33.61 - $49.95 $11.4 Million - $16.9 Million	339,135 New	339,135 $11.6 Million
Q1 2021 May 07, 2021	SELL	$33.61 - $49.95 $11.3 Million - $16.7 Million	-334,857 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$26.52 - $49.35 $8.88 Million - $16.5 Million	334,857 New	334,857 $15.2 Million
Q4 2020 Feb 10, 2021	SELL	$26.52 - $49.35 $8.72 Million - $16.2 Million	-328,865 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$27.01 - $40.26 $8.88 Million - $13.2 Million	328,865 New	328,865 $9.05 Million
Q3 2020 Nov 10, 2020	SELL	$27.01 - $40.26 $9.6 Million - $14.3 Million	-355,378 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$27.75 - $43.44 $9.86 Million - $15.4 Million	355,378 New	355,378 $13.1 Million
Q2 2020 Aug 07, 2020	SELL	$27.75 - $43.44 $10.3 Million - $16.2 Million	-372,310 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$21.5 - $54.2 $8 Million - $20.2 Million	372,310 New	372,310 $12.1 Million
Q1 2020 May 08, 2020	SELL	$21.5 - $54.2 $8 Million - $20.2 Million	-372,310 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$34.54 - $44.87 $12.9 Million - $16.7 Million	372,310 New	372,310 $15.3 Million
Q4 2019 Feb 12, 2020	SELL	$34.54 - $44.87 $12.9 Million - $16.7 Million	-372,310 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$31.84 - $50.88 $11.9 Million - $18.9 Million	372,310 New	372,310 $13.3 Million
Q3 2019 Nov 08, 2019	SELL	$31.84 - $50.88 $10.7 Million - $17.1 Million	-335,269 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$42.0 - $59.29 $14.1 Million - $19.9 Million	335,269 New	335,269 $17.2 Million
Q2 2019 Aug 09, 2019	SELL	$42.0 - $59.29 $13.3 Million - $18.8 Million	-316,423 Closed	0 $0
Q1 2019 May 11, 2020	BUY	$40.82 - $62.45 $2.41 Million - $3.69 Million	59,024 Added 22.93%	316,423 $18.1 Million
Q4 2018 Mar 04, 2019	BUY	$39.11 - $75.15 $10.1 Million - $19.3 Million	257,399 New	257,399 $10.8 Million
Q4 2018 Feb 08, 2019	SELL	$39.11 - $75.15 $8.51 Million - $16.4 Million	-217,664 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$65.0 - $82.15 $14.1 Million - $17.9 Million	217,664 New	217,664 $16.4 Million

Others Institutions Holding RGNX

# of Institutions

197

Shares Held

43.2M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $413M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account